Amoxicillin Shortage Impacting Nearly 75% of Pharmacists Nationwide
Drug Topics
FEBRUARY 24, 2023
Pharmacists generally agree that domestic production of the commonly used antibiotic could prevent more shortages from happening in the future
Fri.Feb 24, 2023
187 
First successful CAR-T treatment for muscle inflammation
European Pharmaceutical Review
FEBRUARY 24, 2023
University Hospital Erlangen in Germany is the first in the world to use chimeric antigen receptor (CAR) T-cells to successfully treat a patient suffering from a severe case of muscle inflammation (myositis). The researchers noted that risk of developing a very severe form of the autoimmune inflammatory disease is high. The patient who received the CAR T treatment was diagnosed with anti-synthetase syndrome.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Organizations, Pharmacists Urge Flu Vaccine for Patients With Diabetes
Drug Topics
FEBRUARY 24, 2023
Leading health organizations are urging those with diabetes and other chronic conditions to get the influenza vaccine.
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Triple-Combination, Fixed-Dose Acne Gel Shows Promise as Treatment
Drug Topics
FEBRUARY 24, 2023
The once-daily, triple-combination gel led to a marked reduction in moderate to severe acne.
Opinion: Fixing U.S. public health will require a health-systems revolution — and for physicians to take a backseat
STAT
FEBRUARY 24, 2023
A classic warning in public health goes like this: “A society that spends so much on health care that it cannot or will not spend adequately on other health enhancing activities may actually be reducing the health of its population.” No nation is as guilty of this practice as the United States, with its extremely high health expenditures alongside abysmal population-level health outcomes.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Major coalition of health groups aims to combat health misinformation
Fierce Healthcare
FEBRUARY 24, 2023
Major coalition of health groups aims to combat health misinformation rking Fri, 02/24/2023 - 11:17
Opinion: Needed: a new framework to make sure health companies play fair with patient data
STAT
FEBRUARY 24, 2023
As a health policy wonk and health economist who has worked in pharmaceutical companies in the United States, Latin America, and Europe, I’ve seen vast volumes of data generated, gathered, aggregated, analyzed, shared, and resold by health care companies and organizations. In my studies with the world’s top medical statistics experts at the University of Oxford’s Centre for Evidence Based Medicine, I’ve also seen how flawed many datasets are, missing critical data pie
Vitiligo treatment gets positive CHMP opinion
European Pharmaceutical Review
FEBRUARY 24, 2023
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ruxolitinib cream (Opzelura ) for non-segmental vitiligo with facial involvement in people over 12 years old. “With no centrally approved treatment option currently available in the EU, this positive opinion marks a significant milestone for the vitiligo community,” explained Dr Steven Stein, Chief Medical Officer, Chief Medical Officer, Incyte.
STAT+: Little transparency, lots of waste: NIH funds pediatric research, but many trials results go unpublished
STAT
FEBRUARY 24, 2023
The National Institutes of Health provided $362 million in grants for clinical trials that enrolled at least 41,000 children over a recent three-year period — but many results were never published, a new analysis found. The results are a worrisome sign of a lack of transparency that can lead to wasted research funding. Specifically, just under two-thirds of the 354 trials studied were registered in advance with ClinicalTrials.gov , the federal database, and just 13% of finished trials wer
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Cardinal Health report examines shifts in biosimilars industry
Drug Store News
FEBRUARY 24, 2023
The study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments.
VP Harris: Abortion pill case could take ‘constitutional right’ from Americans
STAT
FEBRUARY 24, 2023
A looming Texas court decision on abortion pills could impact nationwide access to medication, Vice President Kamala Harris warned Friday, as she described abortion access as a “constitutional right.” The decision — which could be handed down as early as Friday — could yank mifepristone off the market more than two decades after the pill, also used to treat miscarriage, was approved by the Food and Drug Administration.
Butterfly takes flight: Hand-held ultrasound pushed to the limits to test its use for space missions
Fierce Healthcare
FEBRUARY 24, 2023
Butterfly takes flight: Hand-held ultrasound pushed to the limits to test its use for space missions agliadkovskaya Fri, 02/24/2023 - 15:22
A dozen states sue the FDA in hopes of easing abortion pill restrictions
STAT
FEBRUARY 24, 2023
In the latest flare up over access to the abortion pill, a dozen states filed a lawsuit to force the U.S. Food and Drug Administration to ease restrictions on how mifepristone is prescribed and made available to patients. At issue is a risk mitigation program, which is used to ensure certain prescription medicines considered to carry significant risks are prescribed and taken safely.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
What Makes Your Pharmacy Unique?
DiversifyRx
FEBRUARY 24, 2023
The other USP your pharmacy needs to rule your market When pharmacists see USP, our brains automatically translate it to United States Pharmacopoeia. Which is a critically important USP for pharmacies. However, there is another USP that is vitally important if you are a pharmacy owner. Unique Selling Proposition, aka USP. This is a marketing term that essentially answers the question, what makes your pharmacy unique and who benefits the most from that uniqueness.
The best SingleCare reviews this February
The Checkup by Singlecare
FEBRUARY 24, 2023
What was your favorite thing about February? Maybe it was spending Valentine’s Day with your sweetheart or watching the Chiefs win the Super Bowl. Or maybe, if you’re a cold weather lover, it was when Phil the groundhog saw his shadow , predicting another 6 weeks of winter! Did you know that February is also American Heart Month? At SingleCare, we want to help you look after your cardiovascular health.
STAT+: FDA’s top tobacco regulator is ready to talk about the benefits of e-cigs versus cigarettes
STAT
FEBRUARY 24, 2023
WASHINGTON — The head of the FDA’s tobacco center wants to do more to tout the health benefits of switching from cigarettes to e-cigarettes, now that youth vaping rates are declining. “With the reductions in [youth vaping rates] that we’ve seen, we’ve got an opportunity to ramp up our efforts related to the continuum of risk,” said Brian King, director of the FDA’s Center for Tobacco Products, at a Friday event.
Rimegepant rejected by NICE for treatment of acute migraine
Hospital Pharmacy Europe
FEBRUARY 24, 2023
In the UK, NICE has rejected rimegepant for the acute treatment of migraine either with or without aura as well as for episodic attacks An appraisal consultation document from NICE , has rejected the use of rimegepant, within its marketing authorisation, for the acute treatment of migraine with or without aura in adults, or for the prevention of episodic migraine in adults, who experience at least 4 attacks per month.
Taking advantage of protein charge properties for challenging separations
European Pharmaceutical Review
FEBRUARY 24, 2023
The removal/separation of impurities and ensuring the purity of biologics is essential to the safety and quality of the therapeutic. Not only can impurities lead to adverse effects in patients, but they can also introduce product variability. The risks linked to contamination have led regulatory bodies, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to implement strict requirements on process characterisation and validation.
Optum report: Alzheimer's drugs key for payers to watch in Q1
Fierce Healthcare
FEBRUARY 24, 2023
Optum report: Alzheimer's drugs key for payers to watch in Q1 pminemyer Fri, 02/24/2023 - 16:18
Hostess’ Kazbars combine snack cakes, candy bars
Drug Store News
FEBRUARY 24, 2023
Kazbars contain a soft layer of chocolate cake, crème, candy crunch, caramel or smooth chocolate fudge, and are covered in a rich chocolate-flavored coating.
VA taps 10 digital health innovators for $20M challenge to reduce veteran suicide
Fierce Healthcare
FEBRUARY 24, 2023
VA taps 10 digital health innovators for $20M challenge to reduce veteran suicide agliadkovskaya Fri, 02/24/2023 - 17:23
STAT+: Pharmalittle: Moderna pays NIH for Covid vaccine technique; first trial over Zantac cancer claims is postponed
STAT
FEBRUARY 24, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascot, catch up on our paperwork and hold our weekly listening party with Mrs. Pharmalot (the rotation will include this, this and this ).
Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator
Fierce Pharma
FEBRUARY 24, 2023
Merck's COVID pill Lagevrio takes another hit with thumbs-down from EU regulator kdunleavy Fri, 02/24/2023 - 09:38
Haus Labs by Lady Gaga’s Color Fuse Blush melts into skin
Drug Store News
FEBRUARY 24, 2023
The Color Fuse Blush features a gel powder formula that melts into the skin and leaves a second-skin finish with color that lasts, the company said.
Study: Why employers expect to be offering health coverage for the long haul
Fierce Healthcare
FEBRUARY 24, 2023
Study: Why employers expect to be offering health coverage for the long haul fdiamond Fri, 02/24/2023 - 14:47
FDA Approves Efanesoctocog Alfa to Treat Hemophilia A
Drug Topics
FEBRUARY 24, 2023
Efanesoctocog alfa is a recombinant factor VIII therapy with once-a-week dosing.
14 rural senators push CMS to extend low-wage hospitals' payment bump in FY2024
Fierce Healthcare
FEBRUARY 24, 2023
14 rural senators push CMS to extend low-wage hospitals' payment bump in FY2024 dmuoio Fri, 02/24/2023 - 16:34
Collaboration to support quality production of biologics
European Pharmaceutical Review
FEBRUARY 24, 2023
A new collaboration between US Pharmacopeia (USP) and American Type Culture Collection (ATCC), a biological materials management and standards organisation will provide co-branded reference materials and reference standards to advance the quality and development of biologics. “By combining our strengths, we can better support institutions and stakeholders that engage in R&D, process development and release of biologics, as well as provide them with quality products that meet their needs,” co
As SNAP benefits wane, food-as-medicine companies carve out a niche in healthcare
Fierce Healthcare
FEBRUARY 24, 2023
As SNAP benefits wane, food-as-medicine companies carve out a niche in healthcare aburky Fri, 02/24/2023 - 16:56
GSK's first state-level Zantac trial delayed as judge reviews science behind the arguments: report
Fierce Pharma
FEBRUARY 24, 2023
GSK's first state-level Zantac trial delayed as judge reviews science behind the arguments: report fkansteiner Fri, 02/24/2023 - 10:28
Mucinex kicks off ‘Small But Mighty’ campaign with Olympic gold medalist Chloe Kim
Drug Store News
FEBRUARY 24, 2023
Mucinex also is spotlighting small but mighty communities with $100,000 in donations to select community YMCAs.
US primary care system suffering from 'chronic lack of adequate support,' scorecard report finds
Fierce Healthcare
FEBRUARY 24, 2023
US primary care system suffering from 'chronic lack of adequate support,' scorecard report finds dmuoio Fri, 02/24/2023 - 13:24
Target investing $100M to expand next-day delivery services
Drug Store News
FEBRUARY 24, 2023
Target plans to spend $100 million to expand its package-sorting network to more than 15 facilities by the end of 2026.
Let's personalize your content